NMR-Based screening for inborn errors of metabolism: Initial results from a study on Turkish neonates

JIMD Reports

Volumn 16, Issue , 2014, Pages 101-111

  Aygen, Sitke ^a   Dürr, Ulrich ^a   Hegele, Peter ^a   Kunig, Johannes ^a   Spraul, Manfred ^b   Schäfer, Hartmut ^b   Krings, David ^b   Cannet, Claire ^b   Fang, Fang ^b   Schütz, Birk ^b   Bülbül, Selda F H ^c   Aydin, H Ibrahim ^d   Sarıcı, S Ümit ^d   Yalaz, Mehmet ^e   Örs, Rahmi ^f   Atalan, Resit ^g   Tuncer, Oğuz ^h  

^a Institut for Biomedizinische Analytik und NMRImaging   (Germany)

^b BRUKER BIOSPIN GMBH   (Germany)

^c KIRIKKALE UNIVERSITY   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

^e EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^f SELCUK UNIVERSITY   (Turkey)

^g Istanbul i li Hamidiye Etfal E itim ve Ara tirma Hastanesi   (Turkey)

^h YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Biotinidase deficiency; Congenital hypothyroidism; Healthy neonate; Metabolic fingerprint; Untargeted analysis

Indexed keywords

EID: 84973236606     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2014_326     Document Type: Chapter

References (22)

1. Assfalg M, Bertini I, Colangiuli D, Luchinat C, Schäafer H, Schutz B, Spraul M (2008) Evidence of different metabolic phenotypes in humans. PNAS 105:1420–1424
2. Aygen S, Spraul M, Schäafer H et al (2011) Urine based newborn screening study applying high-resolution NMR spectroscopy in Turkey. J Inherit Metab Dis 34(Suppl 3):S256
3. Bernini P, Bertini I, Luchinat C et al (2009) Individual human phenotypes in metabolic space and time. J Proteome Res 8:4264–4271
4. Blau N, Duran M, Blaskovics ME, Gibson KM (2003) Laboratory diagnosis of metabolic diseases (2nd edn, 2nd Printing 2005) Springer-Verlag, Berlin Heidelberg pp 146–147
5. Chace DH, Kalas TA (2005) A biochemical perspective on the use of tandem mass spectrometry for new born screening and clinical testing. Clin Biochem 38:296–309
6. Dietz B, Aksu F, Aguigah G, Witting W, Aygen S, Lehnert W, Jakobs C (1996) Vigabatrintherapie bei einem 7jäahrigen Jungen mit Succinat-Semialdehyd-Dehydrogenase-Mangel. Monatschr Kinderheilkund 144:797–802
7. Engelke UFH, Sass JO, Van Coster RN et al (2008) NMR spectroscopy of aminoacylase 1 deficiency, a novel inborn error of metabolism. NMR Biomed 21:138–147
8. Hasanoglu A, Täumer L, Biberoglu G, Ezgu FS (2000) Ten years experience of a metabolic investigation laboratory in Turkey. Gazi Med J 11:77–80
9. Hastie T, Tibshirani R, Friedman J (2009) The elements of statistical learning. In: Data mining, inference, and prediction, 2nd edn. Springer series in statistics. Springer
10. 1H NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. J Pharmaceut Biomed Anal 15:1647–1659
11. Lehotay DC, Hall P, Lepage J, Eichhorst JC, Etter ML, Greenberg CR (2011) LC-MS/MS progress in newborn screening. Clin Biochem 44:21–31
12. Leonard JV, Morris AA (2006) Diagnosis and early management of inborn errors of metabolism presenting around the time of birth. Acta Paediatr 95:6–14
13. Mohammadi M, Midi H, Arasan J, Al-Talib B (2011) High breakdown estimators to robustify phase II multivariate control charts. J Appl Sci 11:503–511
14. Moolenaar SH, Engelke UFH, Wevers RA (2003) Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann Clin Biochem 40:16–24
15. Nicholson JK, Holmes E, Kinross JM, Darzi AW, Takats Z, Lindon JC (2012) Metabolic phenotyping in clinical and surgical environments. Nature 491:384–392
16. Pomerantsev AL (2008) Acceptance areas for multivariate classification derived by projection methods. J Chemometrics 22:601–609
17. Saudubray JM, Sedel F, Walter JH (2006) Clinical approach to treatable inborn metabolic diseases: an introduction J Inherit Metab Dis 29:261–274
18. Scott CR (2006) The genetic tyrosinemias. Am J Med Genet C Semin Med Genet 142C:121–125
19. Tomoeda K, Awata H, Matsuura T et al (2000) Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. Mol Genet Metab 71:506–510
20. Vanderginste BGM, Massart DL, Buydens LMC et al (1998) Handbook of chemometrics and qualimetrics: Part B. Elsevier
21. 1H-NMR spectroscopy of blood plasma for metabolic studies. Clin Chem 40:1245–1250
22. 1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin Chem 45:539–548